The NF-βB inhibitory proteins IκBα and IκBβ mediate disparate responses to inflammation in fetal pulmonary endothelial cells

Journal of Immunology

Volumn 190, Issue 6, 2013, Pages 2913-2923

  Tang, Jen Ruey ^a   Michaelis, Katherine A ^a   Eva, Nozik Grayck ^a   Seedorf, Gregory J ^a   Marlena, Hartman Filson ^a   Abman, Steven H ^a   Wright, Clyde J ^a  

^a CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; CASPASE 3; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MANGANESE SUPEROXIDE DISMUTASE; PADGEM PROTEIN; PARTHENOLIDE; SUPEROXIDE DISMUTASE; VASCULOTROPIN RECEPTOR 2; ANTIOXIDANT; AUTACOID; I KAPPA B; I KAPPA B BETA; I KAPPA B KINASE; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FETUS; GEL MOBILITY SHIFT ASSAY; INFLAMMATION; LUNG ENDOTHELIUM; NEWBORN; NONHUMAN; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DRUG ANTAGONISM; ENZYMOLOGY; IMMUNOLOGY; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; APOPTOSIS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FETUS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; INFLAMMATION MEDIATORS; LUNG; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

MLCS; MLOWN;

EID: 84874827279     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202670     Document Type: Article

References (64)

1. Thomas, W., and C. P. Speer. 2011. Chorioamnionitis: important risk factor or innocent bystander for neonatal outcome? Neonatology 99: 177-187.
2. Hartling, L., Y. Liang, and T. Lacaze-Masmonteil. 2012. Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and metaanalysis. Arch. Dis. Child. Fetal Neonatal Ed. 97: F8-F17.
3. Woldesenbet, M., and J. M. Perlman. 2005. Histologic chorioamnionitis: an occult marker of severe pulmonary hypertension in the term newborn. J. Perinatol. 25: 189-192.
4. Woldesenbet, M., C. R. Rosenfeld, O. Ramilo, S. Johnson-Welch, and J. M. Perlman. 2008. Severe neonatal hypoxic respiratory failure correlates with histological chorioamnionitis and raised concentrations of interleukin 6 (IL6), IL8 and C-reactive protein. Arch. Dis. Child. Fetal Neonatal Ed. 93: F413-F417.
5. Jakkula, M., T. D. Le Cras, S. Gebb, K. P. Hirth, R. M. Tuder, N. F. Voelkel, and S. H. Abman. 2000. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 279: L600-L607.
6. Abman, S. H. 2001. Bronchopulmonary dysplasia: "a vascular hypothesis." Am. J. Respir. Crit. Care Med. 164: 1755-1756.
7. Stenmark, K. R., and S. H. Abman. 2005. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu. Rev. Physiol. 67: 623-661.
8. Thébaud, B., and S. H. Abman. 2007. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am. J. Respir. Crit. Care Med. 175: 978-985.
9. Abman, S. H. 2010. Impaired vascular endothelial growth factor signaling in the pathogenesis of neonatal pulmonary vascular disease. Adv. Exp. Med. Biol. 661: 323-335.
10. Moss, T. J., J. P. Newnham, K. E. Willett, B. W. Kramer, A. H. Jobe, and M. Ikegami. 2002. Early gestational intra-amniotic endotoxin: lung function, surfactant, and morphometry. Am. J. Respir. Crit. Care Med. 165: 805-811.
11. Kallapur, S. G., C. J. Bachurski, T. D. Le Cras, S. N. Joshi, M. Ikegami, and A. H. Jobe. 2004. Vascular changes after intra-amniotic endotoxin in preterm lamb lungs. Am. J. Physiol. Lung Cell. Mol. Physiol. 287: L1178-L1185.
12. Polglase, G. R., S.B. Hooper, A. W. Gill,B. J. Allison, K. J. Crossley, T. J. M. Moss, I. Nitsos, J. J. Pillow, and M. Kluckow. 2010. Intrauterine inflammation causes pulmonary hypertension and cardiovascular sequelae in preterm lambs. J. Appl. Physiol. 108: 1757-1765.
13. Tang, J. R., G. J. Seedorf, V. Muehlethaler, D. L. Walker, N. E. Markham, V. Balasubramaniam, and S. H. Abman. 2010. Moderate postnatal hyperoxia accelerates lung growth and attenuates pulmonary hypertension in infant rats after exposure to intra-amniotic endotoxin. Am. J. Physiol. Lung Cell. Mol. Physiol. 299: L735-L748.
14. Frank, L., J. Yam, and R. J. Roberts. 1978. The role of endotoxin in protection of adult rats from oxygen-induced lung toxicity. J. Clin. Invest. 61: 269-275.
15. Tang, G., J. T. Berg, J. E. White, P. D. Lumb, C. Y. Lee, and M. F. Tsan. 1994. Protection against oxygen toxicity by tracheal insufflation of endotoxin: role of Mn SOD and alveolar macrophages. Am. J. Physiol. 266: L38-L45.
16. White, C. W., Y. Lewis-Molock, K. Suzuki, N. Taniguchi, H. Shimizu, D. D. Nguyen, and R. J. Mason. 1994. Effects of cytokines and endotoxin on lung manganese superoxide dismutase expression and immunohistochemical distribution. Chest 105(Suppl. 3): 85S-86S.
17. Shim, J. W., Y. S. Chang, and W. S. Park. 2008. Intratracheal administration of endotoxin attenuates hyperoxia-induced lung injury in neonatal rats. Yonsei Med. J. 49: 144-150.
18. Sampath, V., A. C. Radish, A. L. Eis, K. Broniowska, N. Hogg, and G. G. Konduri. 2009. Attenuation of lipopolysaccharide-induced oxidative stress and apoptosis in fetal pulmonary artery endothelial cells by hypoxia. Free Radic. Biol. Med. 46: 663-671.
19. Shiki, Y., B. O. Meyrick, K. L. Brigham, and I. M. Burr. 1987. Endotoxin increases superoxide dismutase in cultured bovine pulmonary endothelial cells. Am. J. Physiol. 252: C436-C440.
20. Oeckinghaus, A., and S. Ghosh. 2009. The NF-kB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol. 1: a000034-a000034.
21. Wei, A. C., J. Fan, J. J. Jones, J. E. Hamilton, Y. H. Li, J. C. Marshall, and O. D. Rotstein. 1999. Delayed treatment with diethyl maleate prevents E-selectin expression in human endothelial cells. Surgery 126: 286-292.
22. Chan, E. L., S. B. Haudek, B. P. Giroir, and J. T. Murphy. 2001. Human coronary endothelial cell activation by endotoxin is characterized by NF-kB activation and TNF-a synthesis. Shock 16: 349-354.
23. Fan, J., R. D. Ye, and A. B. Malik. 2001. Transcriptional mechanisms of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 281: L1037-L1050.
24. Ding, J., D. Song, X. Ye, and S. F. Liu. 2009. A pivotal role of endothelialspecific NF-kB signaling in the pathogenesis of septic shock and septic vascular dysfunction. J. Immunol. 183: 4031-4038.
25. Ye, X., J. Ding, X. Zhou, G. Chen, and S. F. Liu. 2008. Divergent roles of endothelial NF-kB in multiple organ injury and bacterial clearance in mouse models of sepsis. J. Exp. Med. 205: 1303-1315.
26. Ben-Neriah, Y., and M. Karin. 2011. Inflammation meets cancer, with NF-kB as the matchmaker. Nat. Immunol. 12: 715-723.
27. Morgan, M. J., and Z. G. Liu. 2011. Crosstalk of reactive oxygen species and NF-kB signaling. Cell Res. 21: 103-115.
28. Hartney, T., R. Birari, S. Venkataraman, L. Villegas, M. Martinez, S. M. Black, K. R. Stenmark, and E. Nozik-Grayck. 2011. Xanthine oxidase-derived ROS upregulate Egr-1 via ERK1/2 in PA smooth muscle cells; model to test impact of extracellular ROS in chronic hypoxia. PLoS One 6: e27531.
29. Konduri, G. G., J. Ou, Y. Shi, and K. A. Pritchard, Jr. 2003. Decreased association of HSP90 impairs endothelial nitric oxide synthase in fetal lambs with persistent pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 285: H204-H211.
30. Wright, C. J., F. Agboke, M. Muthu, K. A. Michaelis, M. A. Mundy, P. La, G. Yang, and P. A. Dennery. 2012. Nuclear factor-kB (NF-kB) inhibitory protein IkBb determines apoptotic cell death following exposure to oxidative stress. J. Biol. Chem. 287: 6230-6239.
31. Yang, G., A. Madan, and P. A. Dennery. 2000. Maturational differences in hyperoxic AP-1 activation in rat lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 278: L393-L398.
32. Gien, J., G. J. Seedorf, V. Balasubramaniam, N. Markham, and S. H. Abman. 2007. Intrauterine pulmonary hypertension impairs angiogenesis in vitro: role of vascular endothelial growth factor nitric oxide signaling. Am. J. Respir. Crit. Care Med. 176: 1146-1153.
33. Kiningham, K. K., Y. Xu, C. Daosukho, B. Popova, and D. K. St Clair. 2001. Nuclear factor kB-dependent mechanisms coordinate the synergistic effect of PMA and cytokines on the induction of superoxide dismutase 2. Biochem. J. 353: 147-156.
34. St Clair, D. K., S. Porntadavity, Y. Xu, and K. Kiningham. 2002. Transcription regulation of human manganese superoxide dismutase gene. Methods Enzymol. 349: 306-312.
35. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IkB-b regulates the persistent response in a biphasic activation of NF-kB. Cell 80: 573-582.
36. Sen, R., and S. T. Smale. 2010. Selectivity of the NF-kB response. Cold Spring Harb. Perspect. Biol. 2: a000257.
37. Tam, W. F., and R. Sen. 2001. IkappaB family members function by different mechanisms. J. Biol. Chem. 276: 7701-7704.
38. Suyang, H., R. Phillips, I. Douglas, and S. Ghosh. 1996. Role of unphosphorylated, newly synthesized IkBb in persistent activation of NF-kB. Mol. Cell. Biol. 16: 5444-5449.
39. Tran, K., M. Merika, and D. Thanos. 1997. Distinct functional properties of IkBa and IkBb. Mol. Cell. Biol. 17: 5386-5399.
40. Malek, S., D. B. Huang, T. Huxford, S. Ghosh, and G. Ghosh. 2003. X-ray crystal structure of an IkBb 3 NF-kB p65 homodimer complex. J. Biol. Chem. 278: 23094-23100.
41. Hoffmann, A., A. Levchenko, M. L. Scott, and D. Baltimore. 2002. The IkB-NFkB signaling module: temporal control and selective gene activation. Science 298: 1241-1245.
42. Meyrick, B. O., U. S. Ryan, and K. L. Brigham. 1986. Direct effects of E. coli endotoxin on structure and permeability of pulmonary endothelial monolayers and the endothelial layer of intimal explants. Am. J. Pathol. 122: 140-151.
43. Ohnishi, M., N. Imanishi, and S. J. Tojo. 1999. Protective effect of anti-Pselectin monoclonal antibody in lipopolysaccharide-induced lung hemorrhage. Inflammation 23: 461-469.
44. Rao, P., M. S. Hayden, M. Long, M. L. Scott, A. P. West, D. Zhang, A. Oeckinghaus, C. Lynch, A. Hoffmann, D. Baltimore, and S. Ghosh. 2010. IkBb acts to inhibit and activate gene expression during the inflammatory response. Nature 466: 1115-1119.
45. Scheibel, M., B. Klein, H. Merkle, M. Schulz, R. Fritsch, F. R. Greten, M. C. Arkan, G. Schneider, and R. M. Schmid. 2010. IkBb is an essential coactivator for LPS-induced IL-1b transcription in vivo. J. Exp. Med. 207: 2621- 2630.
46. Han, S. J., H. M. Ko, J. H. Choi, K. H. Seo, H. S. Lee, E. K. Choi, I. W. Choi, H. K. Lee, and S. Y. Im. 2002. Molecular mechanisms for lipopolysaccharideinduced biphasic activation of nuclear factor-kB (NF-kB). J. Biol. Chem. 277: 44715-44721.
47. Gilmore, T. D., and M. Herscovitch. 2006. Inhibitors of NF-kB signaling: 785 and counting. Oncogene 25: 6887-6899.
48. Li, X., X. Cui, Y. Li, Y. Fitz, L. Hsu, and P. Q. Eichacker. 2006. Parthenolide has limited effects on nuclear factor-kb increases and worsens survival in lipopolysaccharide-challenged C57BL/6J mice. Cytokine 33: 299-308.
49. Magni, P., M. Ruscica, E. Dozio, E. Rizzi, G. Beretta, and R. Maffei Facino. 2012. Parthenolide inhibits the LPS-induced secretion of IL-6 and TNF-a and NF-kB nuclear translocation in BV-2 microglia. Phytother. Res. 26: 1405- 1409.
50. Park, S. J., H. J. Shin, and H. S. Youn. 2011. Parthenolide inhibits TRIFdependent signaling pathway of Toll-like receptors in RAW264.7 macrophages. Mol. Cells 31: 261-265.
51. Sheehan, M., H. R. Wong, P. W. Hake, and B. Zingarelli. 2003. Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis. Crit. Care Med. 31: 2263-2270.
52. Pakala, S. B., S. D. Reddy, T. M. Bui-Nguyen, S. S. Rangparia, A. Bommana, and R. Kumar. 2010. MTA1 coregulator regulates LPS response via MyD88- dependent signaling. J. Biol. Chem. 285: 32787-32792.
53. De Silva, D., M. D. Mitchell, and J. A. Keelan. 2010. Inhibition of choriodecidual cytokine production and inflammatory gene expression by selective I-kB kinase (IKK) inhibitors. Br. J. Pharmacol. 160: 1808-1822.
54. Kang, B. Y., S. W. Chung, and T. S. Kim. 2001. Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by parthenolide, a predominant sesquiterpene lactone in Tanacetum parthenium: involvement of nuclear factor-kB. Immunol. Lett. 77: 159-163.
55. Yip, K. H., M. H. Zheng, H. T. Feng, J. H. Steer, D. A. Joyce, and J. Xu. 2004. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kB activity. J. Bone Miner. Res. 19: 1905-1916.
56. Uchi, H., J. F. Arrighi, J. P. Aubry, M. Furue, and C. Hauser. 2002. The sesquiterpene lactone parthenolide inhibits LPS- but not TNF-a-induced maturation of human monocyte-derived dendritic cells by inhibition of the p38 mitogenactivated protein kinase pathway. J. Allergy Clin. Immunol. 110: 269-276.
57. Wong, H. R., and I. Y. Menendez. 1999. Sesquiterpene lactones inhibit inducible nitric oxide synthase gene expression in cultured rat aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 262: 375-380.
58. López-Franco, O., P. Hernández-Vargas, G. Ortiz-Munoz, G. Sanjuán, Y. Suzuki, L. Ortega, J. Blanco, J. Egido, and C. Gómez-Guerrero. 2006. Parthenolide modulates the NF-kB mediated inflammatory responses in experimental atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26: 1864-1870.
59. Saadane, A., S. Masters, J. DiDonato, J. Li, and M. Berger. 2007. Parthenolide inhibits IkB kinase, NF-kB activation, and inflammatory response in cystic fibrosis cells and mice. Am. J. Respir. Cell Mol. Biol. 36: 728-736.
60. Sheehan, M., H. R. Wong, P. W. Hake, V. Malhotra, M. O'Connor, and B. Zingarelli. 2002. Parthenolide, an inhibitor of the nuclear factor-kB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents. Mol. Pharmacol. 61: 953-963.
61. Fiebich, B. L., K. Lieb, S. Engels, and M. Heinrich. 2002. Inhibition of LPSinduced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells. J. Neuroimmunol. 132: 18-24.
62. Hwang, D., N. H. Fischer, B. C. Jang, H. Tak, J. K. Kim, and W. Lee. 1996. Inhibition of the expression of inducible cyclooxygenase and proinflammatory cytokines by sesquiterpene lactones in macrophages correlates with the inhibition of MAP kinases. Biochem. Biophys. Res. Commun. 226: 810-818.
63. Saadane, A., J. Eastman, M. Berger, and T. L. Bonfield. 2011. Parthenolide inhibits ERK and AP-1 which are dysregulated and contribute to excessive IL-8 expression and secretion in cystic fibrosis cells. J. Inflamm. 8: 26.
64. Tergaonkar, V., R. G. Correa, M. Ikawa, and I. M. Verma. 2005. Distinct roles of IkB proteins in regulating constitutive NF-kB activity. Nat. Cell Biol. 7: 921-923.